ABOUT ISODIOL INTERNATIONAL
To develop over-the-counter and pharmaceutical drugs utilizing our phytoceutical portfolio and aggressively continue international expansion into Latin America, Asia and Europe.
Isodiol’s leadership team manages a growing global wellness company and are the visionaries behind some of the most respected brands in the Cannabis industry. Their strategic direction for Isodiol International focuses on generating the highest quality phytoceutical consumer products and fostering innovation in pharmaceutical grade compound, while expanding into new markets around the world.
PRESIDENT ISO INTERNATIONAL, LLC
COO ISO INTERNATIONAL, LLC
Isodiol International, Inc., together with its subsidiaries and affiliates, is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.
Isodiol is the trusted producer of raw ingredients, consumer packaged goods such as dietary supplements, food & beverages, skin care, and pharmaceutical products for the international healthcare market.
HISTORY OF ISODIOL
Naturally derived Cannabidiol from Industrial Hemp was discovered for the worldwide market
Executed two years of government contracts to grow and extract from Hemp
ISO99 Developed: An isolated ≥99% pure, dry form of refined Hemp oil
Cebediol(TM) Developed: Micro-encapsulation used on Anhydrous Hemp Oil
Two years of clinical studies performed
NanoUltra(TM) Created: Nanoemulsified Anhydrous Hemp Oil suspended in water for use in food & bev
HenePlex(TM) Created: Full spectrum nanoemulsified phytocannabinoid complex
Developed OTC compliant topical pain cream
Finished goods consumer brands developed for nutraceutical division
Isodiol International becomes a publicly traded entity in Canada under the CSE symbol: ISOL
Isodiol International, Inc
1212 Austin Ave
Coquitlam, BC V3J 5E7
CEO: Marcos Agramont
Computershare Investor Services Inc.
Canada CSE: ISOL
USA OTC: ISOLF
Short Form Prospectus Issuer: No
Principal Regulator: British Columbia
Date of Formation: June 2, 2014
Jurisdiction Where Formed: British Columbia
Financial Year End: Mar 31
CUSIP Number: 465400L101
Auditor: Charlton & Company